Status:
UNKNOWN
CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Thyroid Nodule
Thyroid Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Contrast-enhanced ultrasound (CEUS) can sensitively show the blood perfusion characteristics of thyroid nodules, which is a useful supplement to gray-scale ultrasound. However, there is no standard co...
Eligibility Criteria
Inclusion
- Participants with thyroid nodules with a solid component ≥5 mm confirmed by conventional ultrasound;
- Participants who underwent conventional ultrasound, contrast-enhanced ultrasound, and fine-needle aspiration biopsy;
- Participants with a final benign or malignant pathological results.
Exclusion
- Participants with cytopathology of Bethesda I, III, or IV and without final benign or malignant pathology；
- Participants with a history of thyroid ablation or surgery;
- Participants with low-quality ultrasound images.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2024
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06146764
Start Date
January 1 2024
End Date
April 15 2024
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China, 510289